AbbVie Inc. — Director's Dealing 2021

Feb 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-02-18

Reporting Person: Strom Carrie C (SVP & Pres Global Allerg Aesth)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-18	Option (right to buy)	$105.92	A	32298	Acquired	2031-02-17	Common stock (32298)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,766 on February 18, 2022 10,766 on February 18, 2023, and 10,766 on February 18, 2024.